HCP (HCP) : Traders are bullish on HCP (HCP) as it has outperformed the S&P 500 by a wide margin of 1.94% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 2.61%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 4.15% in the last 1 week, and is up 6.4% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock. The stock has recorded a 20-day Moving Average of 5.79% and the 50-Day Moving Average is 8.78%.
HCP (NYSE:HCP): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $36.97 and $36.78 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $37.50. The buying momentum continued till the end and the stock did not give up its gains. It closed at $37.43, notching a gain of 1.30% for the day. The total traded volume was 3,757,192 . The stock had closed at $36.95 on the previous day.
The company Insiders own 0.22% of HCP shares according to the proxy statements. Institutional Investors own 91.97% of HCP shares. During last six month period, the net percent change held by insiders has seen a change of 10.13%. In a related news,The officer (Executive Vice President) of Hcp, Inc., Hsiao Kai sold 266 shares at $36.04 on May 9, 2016. The Insider selling transaction had a total value worth of $9,587. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.